Therapeutic efficacy of platelet transfusion treated with amotosalen/UVA pathogen inactivation technology (INTERCEPT<sup>TM</sup> Blood System) in acute myeloid leukemia patients undergoing chemotherapy with curative intent: a single center experience.

Ladaique, Patrick; Etienne, Jean-Michel; Pedini, Pascal; Chiaroni, Jacques; Vey, Norbert; Picard, Christophe; Chabrieres, Corinne

Therapeutic efficacy of platelet transfusion treated with amotosalen/UVA pathogen inactivation technology (INTERCEPT^TM Blood System) in acute myeloid leukemia patients undergoing chemotherapy with curative intent: a single center experience.

Ladaique, Patrick; Etienne, Jean-Michel; Pedini, Pascal; Chiaroni, Jacques; Vey, Norbert; Picard, Christophe; Chabrieres, Corinne.

Affiliation

Ladaique P; Hematology Department, Institut Paoli-Calmettes, Marseille, France.
Etienne JM; EFS PACA-Corse, Marseille, France.
Pedini P; EFS PACA-Corse, Marseille, France.
Chiaroni J; Aix Marseille Université, CNRS, EFS, ADES, Marseille, France.
Vey N; EFS PACA-Corse, Marseille, France.
Picard C; Aix Marseille Université, CNRS, EFS, ADES, Marseille, France.
Chabrieres C; Hematology Department, Institut Paoli-Calmettes, Marseille, France.

Blood Transfus ; 21(5): 400-408, 2023 09.

Article in En | MEDLINE | ID: mdl-36795348

Subject(s)

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myeloid, Acute / Platelet Transfusion Type of study: Etiology_studies / Observational_studies / Risk_factors_studies Limits: Humans Language: En Journal: Blood Transfus Year: 2023 Document type: Article Affiliation country: Francia Country of publication: Italia

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google